Neuropsychopharmacology 2021

5 papers
In 2021, research in *Neuropsychopharmacology* focused on the molecular mechanisms of substance use and the application of computational models to psychiatric treatment. Studies investigated transcriptomic changes in the ventral tegmental area induced by cocaine, with contributions from authors such as Dina P. Matheos and Marcelo A. Wood. The year also featured the proceedings of the 60th Annual Meeting of the American College of Neuropsychopharmacology, which compiled a wide range of abstracts on current neuroscientific developments. Clinical research emphasized the prediction of antidepressant responses using probabilistic graphical models, a direction explored by Madhukar H. Trivedi and Taryn L. Mayes. Other work examined in vivo techniques for measuring prefrontal synaptic strength in relation to depression, schizophrenia, and ketamine administration. Additionally, researchers utilized Bayesian inference to model how dopaminergic control influences impulsivity and risk-seeking behaviors. These contributions highlight a trend toward integrating molecular biology with computational frameworks to better understand and treat mental health disorders.

Top Research Directions

The 9 research directions with Neuropsychopharmacology 2021 papers, ranked by paper count, next to 2020. Share is the fraction of the edition’s papers in the direction.

#Direction20212020Share 2021Share 20202020 rank
1Biological Subtyping to Parse Clinical Heterogeneity1120.0%5.9%3
2Comparative Transcriptomics for Elucidating Cellular Mechanisms1020.0%0.0%—
3Identifying Functional Gene Modules via Co-Expression Networks1020.0%0.0%—
4Interpreting Gene Expression via Functional Enrichment Analysis1020.0%0.0%—
5Master Regulator Discovery in Gene Regulatory Networks1020.0%0.0%—
6Multi State Markov Models for Long Term Clinical Projections1020.0%0.0%—
7Optimizing Predictive Lead Time for Proactive Clinical Intervention1020.0%0.0%—
8The Discordance Between Transcript and Protein Expression1020.0%0.0%—
9Unsupervised Discovery of Latent Clinical Phenotypes1020.0%0.0%—

Download all directions as CSV

Institutions

Institutions credited by Neuropsychopharmacology 2021 papers: a paper credits every institution named in its affiliations, once. 10 institutions share 2 credited papers.

#InstitutionPapersShare20202020 rank
101b3dvp57 150.0%0—
2033ztpr93 150.0%0—
3Duke University 150.0%0—
4Max Planck Institute of Psychiatry 150.0%0—
5Mayo Clinic 150.0%0—
6National University of Singapore 150.0%0—
7The University of Texas Southwestern Medical Center 150.0%0—
8University of California, Irvine 150.0%0—
9University of Illinois Urbana-Champaign 150.0%0—
10Vanderbilt University 150.0%120

Download all institutions as CSV

About this data

Papers. Neuropsychopharmacology 2021 lists 5 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2020 use shares, since the edition went from 17 to 5 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 2 of 5 papers (40.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Neuropsychopharmacology 2021”, https://lacuna.tiptreesystems.com/venue/neuropsychopharmacology/2021.

Impactful Papers

Papers from Neuropsychopharmacology 2021 that shaped research clusters.

Influential

Papers

Title
ACNP 60th Annual Meeting: Poster Abstracts P1 - P275
Cocaine induces paradigm-specific changes to the transcriptome within the ventral tegmental area
Impulsivity and risk-seeking as Bayesian inference under dopaminergic control
Novel approaches to estimate prefrontal synaptic strength in vivo in humans: of relevance to depression, schizophrenia, and ketamine
Prediction of short-term antidepressant response using probabilistic graphical models with replication across multiple drugs and treatment settings